RT Journal Article
SR Electronic
T1 The impact of ethical implications intertwined with tuberculosis household contact investigation: a qualitative study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.27.24309538
DO 10.1101/2024.06.27.24309538
A1 Mlambo, LM
A1 Milovanovic, M
A1 Hanrahan, CF
A1 Motsomi, KW
A1 Morolo, MT
A1 Mohlamonyane, MP
A1 Albaugh, NW
A1 Ahmed, K
A1 Martinson, NA
A1 Dowdy, DW
A1 West, NS.
YR 2024
UL http://medrxiv.org/content/early/2024/06/28/2024.06.27.24309538.abstract
AB Background Household contact investigation (HCI) is an effective and widely used approach to identify persons with tuberculosis (TB) disease and infection, globally. Despite widespread recommendations for the use of HCI, there remains poor understanding of the impact on and value of contact investigation for participants. Further, how HCI as a practice impacts psychosocial factors, including stigma and possible unintended disclosure of illness among persons with TB, their families, and communities, is largely unknown.Methods This exploratory qualitative study nested within a randomized trial (ClinicalTrials.gov: NCT04520113, 17 August 2020) was conducted in South Africa to understand the impacts of HCI on index patients living with TB and their household contact persons in two rural districts in the Limpopo province (Vhembe and Capricorn) and Soshanguve, a peri-urban township in Gauteng province. People with TB and household members of people with TB were recruited to participate in in-depth interviews and focus group discussions using semi-structured guides. We explored individual, interpersonal, and community-level perceptions of potential impacts of household contact investigation to elucidate their perceptions of HCI. Thematic analysis identified key themes.Results Twenty-four individual interviews and six focus group discussions (n=39 participants) were conducted. Participants viewed HCI as an effective approach to finding TB cases, helpful in educating households about TB symptoms and reducing barriers to health-related services. At the interpersonal level, HCI aided people with TB in safely disclosing their TB status to family members and facilitated family and social support for accountability. The introduction of HIV testing during HCI was reported by some participants as making household members slightly uncomfortable, decreasing interest in household members being tested for TB. HCI negatively impacted community-level TB and HIV-related stigma due to healthcare worker visibility at home.Conclusion Our data suggests varying impacts of HCI on people with TB, their families and interpersonal relationships, and communities, highlighting the importance of considering approaches that address concerns about community stigma and HIV testing to enhance acceptance of HCI.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Human Research Ethics Committee at the University of the Witwatersrand (Ethics reference: 1909111B), and by the Institutional Review Board at the Johns Hopkins Bloomberg School of Public Health (IRB reference: 11124). All participants provided written informed consent before enrolment.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData cannot be shared beyond individual quotations in the manuscript because participants did not give consent for the publication of their responses in full, or access to their data to those outside of the research study will have access to participants' data. Requests for data for researchers who meet the criteria for access to confidential data will be considered by the governing IRB on a case by case basis.HCIHousehold Contact InvestigationTBTuberculosisHIVHuman Immunodeficiency VirusWHOWorld Health Organization